A Pilot Study To Examine The Effects Of Ticagrelor To Protect Against Type 2 Diabetes-Induced Vascular Damage

Ticagrelor in Elderly Patients Undergoing Percutaneous Coronary Intervention

NCT04999293 ·Status: COMPLETED

Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting

NCT02487732 ·Status: COMPLETED ·Phase: PHASE4

Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes

NCT01852214 ·Status: COMPLETED ·Phase: NA

Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II

NCT05764356 ·Status: NOT_YET_RECRUITING

Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.

NCT01226602 ·Status: COMPLETED ·Phase: PHASE1

A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge

NCT06301776 ·Status: RECRUITING ·Phase: NA

In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease

NCT05716646 ·Status: NOT_YET_RECRUITING

A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response

NCT03027934 ·Status: WITHDRAWN ·Phase: PHASE4

Stent-Assisted Coiling Followed by Ticagrelor Monotherapy Instead of Dual Antiplatelet Therapy in Unruptured Intracranial Aneurysm

NCT06015477 ·Status: RECRUITING ·Phase: NA

Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With Dabigatran

NCT01595854 ·Status: COMPLETED ·Phase: PHASE1

A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients

NCT04307511 ·Status: RECRUITING ·Phase: PHASE4

Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake

NCT01690884 ·Status: COMPLETED ·Phase: PHASE1

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

NCT01587651 ·Status: COMPLETED ·Phase: PHASE4

The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease

NCT04206176 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Brilinta DaYu Study

NCT01870921 ·Status: COMPLETED ·Phase: PHASE4

The Effect Of Ticagrelor On Saphenous Vein Graft Patency In Patients Undergoing Coronary Artery Bypass Grafting Surgery

NCT02352402 ·Status: UNKNOWN ·Phase: PHASE3

Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study

NCT02091921 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel

NCT02140801 ·Status: COMPLETED ·Phase: PHASE4

Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis

NCT02298088 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI

NCT05015699 ·Status: WITHDRAWN ·Phase: NA

EndoTic - Endothelium and Ticagrelor

NCT02244710 ·Status: COMPLETED ·Phase: NA

Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old

NCT04122170 ·Status: COMPLETED ·Phase: PHASE2

Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects

NCT04088123 ·Status: WITHDRAWN

DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury

NCT02110303 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Impact of Ticagrelor Re-load on Pharmacodynamic Profiles

NCT01731041 ·Status: COMPLETED ·Phase: NA